Cargando…
25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal
Salmonella Typhi, first isolated in 1884, results in infection of the intestines and can end in death and disability. Due to serious adverse events post vaccination, whole cell killed vaccines have been replaced with new generation vaccines. The efficacy of Vi polysaccharide (ViPS) vaccine, a new ge...
Autores principales: | Bajracharya, Deepak, Khan, M. Imran, Pach, Alfred, Shrestha, Parisha, Joshi, Nilesh, Upreti, Shyam R., Wierzba, Thomas, Puri, Mahesh, Sahastrabuddhe, Sushant, Ochiai, R. Leon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882213/ https://www.ncbi.nlm.nih.gov/pubmed/24400067 http://dx.doi.org/10.1371/journal.pone.0077974 |
Ejemplares similares
-
Barriers to typhoid fever vaccine access in endemic countries
por: Khan, M Imran, et al.
Publicado: (2017) -
Social and Economic Burden Associated With Typhoid Fever in Kathmandu and Surrounding Areas: A Qualitative Study
por: Kaljee, Linda M, et al.
Publicado: (2018) -
Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans
por: Sahastrabuddhe, Sushant, et al.
Publicado: (2019) -
Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT)
por: Lee, Eun Young, et al.
Publicado: (2020) -
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
por: Chaudhary, Shipra, et al.
Publicado: (2023)